The acute effect of tropisetron on ECG parameters in cancer patients

Supportive Care in Cancer

Volumn 16, Issue 9, 2008, Pages 1011-1015

  Yavas, Ozlem ^a   Yazici, Mehmet ^a   Eren, Onder ^a   Boruban, Cem ^a   Artac, Mehmet ^a   Genc, Mine ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

5 HT3 receptor antagonist; Cardiotoxicity; ECG; Tropisetron

Indexed keywords

SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CANCER PATIENT; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CHEMOTHERAPY INDUCED NAUSEA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG INDUCED DISEASE; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT DISPERSION; QT INTERVAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CARDIOTOXINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INDOLES; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS;

EID: 49349117927     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0400-2     Document Type: Article

References (23)

1. M Aapro JP Bourke 2003 Rapid intravenous administration of granisetron prior to chemotherapy is not arythmogenic: results of a pilot study Eur J Cancer 39 7 927 931
2. C Antzelevitch GX Yan W Shimizu 1999 Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome J Electrocardiol 32 Suppl 158 165
3. B Audhuy P Cappelaere M Martin 1996 A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy Eur J Cancer 32A 5 807 813
4. HS Ballard G Bottino J Bottino 1992 Ondansetron and chest pain Lancet 340 8827 1107
5. HR Bazett 1920 An analysis of the time relations of electrocardiographs Heart 7 353 370
6. CR Benedict R Arbogast L Martin 1996 Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers J Cardiovasc Pharmacol 28 1 53 59
7. SC Boike B Ilson N Zariffa 1997 Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults Am J Health Syst Pharm 54 10 1172 1176
8. M Buyukavci H Olgun N Ceviz 2005 The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia Am J Clin Oncol 28 2 201 204
9. A Chen FM Kusumoto 2004 QT dispersion: much ado about something Chest 125 6 1974 1977
10. CP Day JM McComb RW Campbell 1990 QT dispersion: an indication of arrhythmia risk in patients with long QT intervals Br Heart J 63 6 342 344
11. JE Gialafos 1999 P-wave dispersion Eur Heart J 20 4 317
12. GW Gray TM McLellan MB Ducharme 1996 Granisetron shows no pro-arrhythmic effect in normal subjects during or after exercise in a hot environment Aviat Space Environ Med 67 8 759 761
13. P Hesketh R Navari T Grote 1996 Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group J Clin Oncol 14 8 2242 2249
14. TL Hunt M Cramer A Shah 1995 A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers J Clin Pharmacol 35 7 705 712
15. IT Jantunen VV Kataja TT Muhonen 1996 Effects of granisetron with doxorubicin or epirubicin on ECG intervals Cancer Chemother Pharmacol 37 5 502 504
16. DL Keefe 2002 The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern Oncologist 7 1 65 72
17. YA Kuryshev AM Brown L Wang 2000 Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels J Pharmacol Exp Ther 295 2 614 620
18. WS Lofters JL Pater B Zee 1997 Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy J Clin Oncol 15 8 2966 2973
19. J Morganroth 2007 Cardiac repolarization and the safety of new drugs defined by electrocardiography Clin Pharmacol Ther 81 1 108 113
20. Morganroth J (2007) Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs. Ernst Schering Res Found Workshop (59):171-184
21. RM Navari 2003 Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting-two new agents J Support Oncol 1 2 89 103
22. JS Perkiomaki 1997 Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction J Am Coll Cardiol 30 5 331 338
23. FM Schnell 2003 Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control Oncologist 8 2 187 198